Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This is a phase II clinical trial assessing the safety and efficacy of sequential systemic
and intraperitoneal (IP) chemotherapy in patients with primary gastric/gastroesophageal
junction cancer with cytology positive peritoneal lavage and/or peritoneal carcinomatosis.